DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dexamethasone (Dexamethasone) - Deep Vein Thrombosis - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Deep Vein Thrombosis ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dexamethasone where reactions include deep vein thrombosis. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of    Next >>

Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-13

Patient:

Reactions: Pulmonary Embolism, Multiple Myeloma, Peripheral Sensory Neuropathy, Constipation, Somnolence, Death, Complications of Transplant Surgery, Peripheral Motor Neuropathy, Thrombosis in Device, Blood Alkaline Phosphatase Increased, Pancytopenia, Multiple Fractures, Rash, Renal Failure, Osteonecrosis of JAW, Embolism, Hypothyroidism, Deep Vein Thrombosis, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral

Thalidomide
    Dosage: or 4 weeks and increased every 4 weeks in 50-mg increments to a maximum of 200mg/day
    Administration route: Oral
    Indication: Multiple Myeloma

Cyclophosphamide
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 20 milligram
    Indication: Multiple Myeloma

Other drugs received by patient: Melphalan Hydrochloride; Prednisolone; CLO; ZOL; Melphalan Hydrochloride; Biphosphonate; Vincristine; Doxorubicin Hydrochloride; Bortezomib



Possible Dexamethasone side effects in

Reported by a physician from Italy on 2012-08-03

Patient:

Reactions: Pyrexia, Constipation, Disease Progression, Liver Disorder, Herpes Zoster, Cardiac Disorder, Death, Neuropathy Peripheral, Oedema, Thrombocytopenia, Hyperglycaemia, Toxicity To Various Agents, Rash, Gastrointestinal Disorder, Pancreatitis, Deep Vein Thrombosis, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 milligram

Bortezomib
    Dosage: 1.3 milligram/sq. meter

Thalidomide
    Dosage: 100 milligram
    Administration route: Oral

Dexamethasone
    Dosage: 40 milligram
    Indication: Multiple Myeloma

Thalidomide
    Dosage: 200 milligram
    Administration route: Oral

Thalidomide
    Dosage: 50 milligram
    Administration route: Oral

Dexamethasone
    Dosage: 40 milligram

Dexamethasone
    Dosage: 40 milligram

Bortezomib
    Dosage: 1.3 milligram/sq. meter
    Indication: Multiple Myeloma

Bortezomib
    Dosage: 1 milligram/sq. meter

Thalidomide
    Dosage: 100 milligram
    Administration route: Oral

Dexamethasone
    Dosage: 40 milligram

Bortezomib
    Dosage: .7 milligram/sq. meter

Thalidomide
    Dosage: 100 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Other drugs received by patient: Acyclovir; Melphalan Hydrochloride; Neupogen; Neupogen; Cyclophosphamide



Possible Dexamethasone side effects in

Reported by a individual with unspecified qualification from Spain on 2012-07-30

Patient:

Reactions: Colon Cancer, Pulmonary Embolism, Toxicity To Various Agents, Multiple Myeloma, Herpes Zoster, Death, Neuropathy Peripheral, Gastrointestinal Disorder, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.3mg/m2 on days 1,4,8 and 11 q 3 weeks
    Indication: Multiple Myeloma

Thalomid
    Dosage: 200mg daily (escalating doses in the first cycle)
    Administration route: Oral
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40mg on days 1-4 and 9-12 at 4-week intervals
    Administration route: Oral
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18

Patient:

Reactions: Pneumonia, Nausea, Lymphopenia, Hyperglycaemia, Anaemia, Febrile Neutropenia, Constipation, Renal Failure, Neuropathy Peripheral, Fatigue, Diarrhoea, Embolism, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Velcade
    Dosage: 1.3 milligram/sq. meter
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Revlimid
    Dosage: 15 milligram
    Administration route: Oral

Cyclophosphamide
    Dosage: 500 milligram/sq. meter
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 milligram/sq. meter

Dexamethasone
    Dosage: 40 milligram
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-07-16

Patient:

Reactions: Graft Versus Host Disease, Pulmonary Embolism, Toxicity To Various Agents, Polyneuropathy, Disease Progression, Death, Embolism Venous, Deep Vein Thrombosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalomid
    Dosage: induction therapy, 200 mg escalated to 400 mg, qd, with vte prophylaxis
    Administration route: Oral
    Indication: Multiple Myeloma

Melphalan Hydrochloride
    Dosage: 200 milligram/sq. meter

Cyclophosphamide
    Dosage: 1000 milligram/sq. meter
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral

Adriamycin PFS
    Dosage: 15 milligram/sq. meter

Thalomid
    Dosage: maintenance therapy, 50 mg qd, without vte prophylaxis
    Administration route: Oral

Adriamycin PFS
    Dosage: 9 milligram/sq. meter
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen; Mycophenolate Mophetil; Cyclosporine; Nadroparine



Possible Dexamethasone side effects in 46 year old male

Reported by a physician from United States on 2012-07-12

Patient: 46 year old male

Reactions: Febrile Neutropenia, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituxan
    Dosage: 698 mg, unk
    Start date: 2012-05-02

Mesna
    Dosage: 1116 mg, unk
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Dosage: 446 mg, unk

Doxorubicin HCL
    Dosage: 56.5 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Pegfilgrastim
    Dosage: 6 mg, unk
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Dosage: 630 mg, q12h
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Vincristine Sulfate
    Dosage: 2 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17

Doxorubicin HCL
    Dosage: 37 mg, unk

Dexamethasone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17

Rituxan
    Dosage: 787.5 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Other drugs received by patient: MS Contin; Valtrex; Omeprazole; Ciprofloxacin; Morphine Sulfate; Enoxaparin / 01708202 /; Compazine; Fluconazole; Metoprolol Tartrate



Possible Dexamethasone side effects in 83 year old male

Reported by a physician from United States on 2012-07-10

Patient: 83 year old male

Reactions: Rectal Cancer, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Revlimid
    Dosage: 25mg daily for days 1-21 or 15mg daily
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-08-02

Dexamethasone
    Dosage: 40mg once a week days 1,8,15,22/ 20mg once a week days 1,8,15,22
    Indication: Multiple Myeloma
    Start date: 2011-08-02

Other drugs received by patient: Meloxicam; Zometa



Possible Dexamethasone side effects in 46 year old male

Reported by a physician from United States on 2012-07-09

Patient: 46 year old male

Reactions: Febrile Neutropenia, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Neulasta

Doxorubicin HCL

Vincristine

Neulasta
    Indication: non-Hodgkin's Lymphoma

Mabthera
    Start date: 2012-05-02

Mabthera
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Vincristine
    Indication: non-Hodgkin's Lymphoma

Mesna

Cyclophosphamide

Dexamethasone
    Administration route: Oral

Mesna
    Indication: non-Hodgkin's Lymphoma

Dexamethasone
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma

Other drugs received by patient: Valtrex; Omeprazole; Fluconazole; Metoprolol; Morphine; Ciprofloxacin; MS Contin; Enoxaparin; Compazine



Possible Dexamethasone side effects in

Reported by a physician from Italy on 2012-06-29

Patient:

Reactions: Anaemia, Febrile Neutropenia, Rash, Multiple Myeloma, Pyrexia, Stem Cell Transplant, Myeloma Recurrence, Neuropathy Peripheral, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Doxorubicin HCL
    Dosage: 300 milligram/sq. meter
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 20 milligram
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in 48 year old male

Reported by a health professional (non-physician/pharmacist) from Turkey on 2012-06-22

Patient: 48 year old male

Reactions: Plasmacytoma, Osteonecrosis, Staphylococcal Abscess, Deep Vein Thrombosis, RIB Fracture, Disease Progression

Drug(s) suspected as cause:
Lenalidomide
    Dosage: 25 mg
    Indication: Multiple Myeloma

Bortezomib
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40 mg
    Indication: Multiple Myeloma

Dexamethasone

Thalidomide
    Dosage: 200 mg
    Indication: Multiple Myeloma

Cyclophosphamide
    Indication: Multiple Myeloma

Aspirin
    Indication: Thrombosis Prophylaxis

Zoledronoc Acid
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in

Reported by a physician from Turkey on 2012-06-13

Patient:

Reactions: Osteonecrosis, Staphylococcal Abscess, RIB Fracture, Deep Vein Thrombosis, Disease Progression

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 unk, unk

Dexamethasone
    Dosage: 40 mg, cyclic
    Administration route: Oral
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Cyclophosphamide
    Dosage: 750 mg/m2, cyclic
    Indication: Multiple Myeloma

Lenalidomide
    Dosage: 25 mg, cyclic
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in

Reported by a physician from Greece on 2012-05-08

Patient:

Reactions: Sudden Death, Orthostatic Hypotension, Constipation, Myalgia, Neuropathy Peripheral, Fatigue, Oedema Peripheral, Hypocalcaemia, Acute Myocardial Infarction, Blood Creatinine Increased, Thrombocytopenia, Hypotension, Hyponatraemia, Rash, Cerebrovascular Accident, Renal Impairment, Diarrhoea, Amyloidosis, Neutropenia, Deep Vein Thrombosis, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Revlimid
    Dosage: 15 milligram
    Administration route: Oral

Dexamethasone
    Dosage: 20 milligram
    Indication: Amyloidosis

Cyclophosphamide
    Dosage: level 0: 50mg, level 1-4: 100mg
    Indication: Amyloidosis

Revlimid
    Dosage: level 0-1: 10mg, level 2: 15mg, level 3: 20mg, level 4: 25mg
    Administration route: Oral
    Indication: Amyloidosis

Revlimid
    Dosage: 15 milligram
    Administration route: Oral

Other drugs received by patient: Aspirin



Possible Dexamethasone side effects in male

Reported by a physician from United States on 2012-04-23

Patient: male

Reactions: Febrile Neutropenia, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegfilgrastim
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Dosage: 56.5 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Cyclophosphamide
    Dosage: 630 mg, q12h
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Vincristine
    Dosage: 2 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Rituximab
    Dosage: 787.5 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Dexamethasone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Other drugs received by patient: Metoprolol Tartrate; MS Contin; Fluconazole; Valtrex; Ciprofloxacin



Possible Dexamethasone side effects in male

Reported by a individual with unspecified qualification from United States on 2012-04-18

Patient: male

Reactions: Febrile Neutropenia, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Vincristine
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Doxorubicin Hydrochloride
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Mabthera
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Neulasta
    Indication: non-Hodgkin's Lymphoma

Dexamethasone
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma

Other drugs received by patient: Metoprolol Tartrate; Fluconazole; Valtrex; Ciprofloxacin Hydrochloride; MS Contin



Possible Dexamethasone side effects in male

Reported by a physician from United States on 2012-04-17

Patient: male

Reactions: Febrile Neutropenia, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Vincristine
    Dosage: 2 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Doxorubicin HCL
    Dosage: 56.5 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Rituximab
    Dosage: 787.5 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Cyclophosphamide
    Dosage: 630 mg, q12h
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Pegfilgrastim
    Indication: non-Hodgkin's Lymphoma

Other drugs received by patient: Ciprofloxacin Hydrochloride; Fluconazole; MS Contin; Valtrex; Metoprolol



Possible Dexamethasone side effects in male

Reported by a individual with unspecified qualification from United States on 2012-04-10

Patient: male

Reactions: Febrile Neutropenia, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mabthera
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Neulasta
    Indication: non-Hodgkin's Lymphoma

Dexamethasone
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Other drugs received by patient: Fluconazole; Valtrex; Metoprolol Tartrate; Ciprofloxacin Hydrochloride; MS Contin



Possible Dexamethasone side effects in male

Reported by a physician from France on 2012-04-04

Patient: male

Reactions: Basal Cell Carcinoma, Deep Vein Thrombosis

Drug(s) suspected as cause:
Lenalidomide
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2012-03-01

Dexamethasone
    Indication: Multiple Myeloma
    Start date: 2008-12-10
    End date: 2010-01-06

Lenalidomide
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2008-12-10

Other drugs received by patient: Omeprazole; Zopiclone; Moviprep; Acetaminophen and Tramadol HCL; Enalapril; Enalapril Maleate; Acetaminophen; Oracillin; Previscan



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from China on 2012-04-02

Patient:

Reactions: Vomiting, Anaemia, Pyrexia, Multiple Myeloma, Constipation, Herpes Zoster, Neuropathy Peripheral, Fatigue, Diarrhoea, Upper Respiratory Tract Infection, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis

Drug(s) suspected as cause:
Thalidomide
    Dosage: initial dose
    Administration route: Oral

Doxorubicin HCL
    Dosage: continuous infusion of days 1-4
    Indication: Multiple Myeloma

Thalidomide
    Dosage: mtd 9maximum tolerated dose
    Administration route: Oral
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: on days 1-4, 9-12 and 17-20, montly minimum of 4 cycles and maximum of 6 cycles
    Administration route: Oral
    Indication: Multiple Myeloma

Vincristine
    Dosage: continuous infusion on days 1-4
    Indication: Multiple Myeloma

Other drugs received by patient: Aspirin



Possible Dexamethasone side effects in male

Reported by a physician from United States on 2012-03-28

Patient: male

Reactions: Febrile Neutropenia, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Cyclophosphamide
    Dosage: 630 mg, q12h
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Pegfilgrastim
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Dosage: 56.5 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Vincristine
    Dosage: 2 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Rituximab
    Dosage: 787.5 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Other drugs received by patient: Valtrex; Fluconazole; Ciprofloxacin; Metoprolol Succinate; MS Contin



Possible Dexamethasone side effects in 77 year old male

Reported by a physician from United States on 2012-03-23

Patient: 77 year old male, weighing 61.2 kg (134.7 pounds)

Reactions: NO Therapeutic Response, Multiple Myeloma, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Indication: Multiple Myeloma
    Start date: 2011-04-01

Revlimid
    Dosage: 10 mg, 1 in 1 d, po, 25 mg, daily for 14 days, po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-04-26

Revlimid
    Dosage: 10 mg, 1 in 1 d, po, 25 mg, daily for 14 days, po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-08-16
    End date: 2011-04-16

Other drugs received by patient: Velcade; Aspirin



Possible Dexamethasone side effects in 61 year old male

Reported by a physician from United States on 2012-03-23

Patient: 61 year old male

Reactions: Pulmonary Embolism, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Indication: Multiple Myeloma
    Start date: 2011-08-24

Revlimid
    Dosage: 25 mg, qd x 14 days, po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-08-24

Velcade
    Indication: Multiple Myeloma
    Start date: 2011-08-24

Other drugs received by patient: Aspirin



Possible Dexamethasone side effects in 63 year old female

Reported by a physician from United States on 2012-03-23

Patient: 63 year old female, weighing 100.7 kg (221.5 pounds)

Reactions: Neurotoxicity, Chest Pain, Pulmonary Embolism, Multiple Myeloma, Pneumonitis, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxil
    Dosage: 40 mg/m2, iv
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 20 mg, ut dict after chemo 1 week later ; 40 mg
    Indication: Product Used FOR Unknown Indication

Revlimid
    Dosage: 25 mg, 1 in 1 d, po ; 10 mg, qd x 21 days, po ; 10 mg, 21 days on/7 days off, po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-04-01

Revlimid
    Dosage: 25 mg, 1 in 1 d, po ; 10 mg, qd x 21 days, po ; 10 mg, 21 days on/7 days off, po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-16

Revlimid
    Dosage: 25 mg, 1 in 1 d, po ; 10 mg, qd x 21 days, po ; 10 mg, 21 days on/7 days off, po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-07-01

Other drugs received by patient: Biaxin; Coumadin; Flexeril; Colace (Docusate Sodium); Lidoderm; Prilosec; Prozac; Arixtra; Gabapentin; Vagifem; Vicodin; Zoledronic Acid; Heparin; Trazodone HCL; Zofran; Albuterol Sulfate; Dilaudid; Lorazepam



Possible Dexamethasone side effects in 62 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-23

Patient: 62 year old female

Reactions: NO Therapeutic Response, Monoclonal Immunoglobulin Present, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Revlimid
    Dosage: 25 mg, daily x 21 days, po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-10-01

Dexamethasone
    Dosage: 40 mg, weekly
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in 56 year old male

Reported by a pharmacist from United States on 2012-03-23

Patient: 56 year old male, weighing 93.8 kg (206.4 pounds)

Reactions: Pulmonary Embolism, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, weekly
    Indication: Multiple Myeloma
    Start date: 2011-11-10

Revlimid
    Dosage: 25 mg, 1 in 1 d, po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-11-10

Other drugs received by patient: Acyclovir; Fentanyl; Gabapentin; Ativan; Nexium; Ambien; Fragmin (Heparin-F-Ractino, Sodium Salt); MLN-9708 (Protease Inhibitors); Bactrim SS (Bactrim); Multivitamin; Vicodin



Possible Dexamethasone side effects in male

Reported by a individual with unspecified qualification from United States on 2012-03-21

Patient: male

Reactions: Febrile Neutropenia, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Neulasta
    Indication: non-Hodgkin's Lymphoma

Mabthera
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Dexamethasone
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Vincristine
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Other drugs received by patient: Fluconazole; MS Contin; Metoprolol Succinate; Valtrex; Ciprofloxacin



Possible Dexamethasone side effects in

Reported by a physician from Sweden on 2012-03-21

Patient:

Reactions: Haemorrhage, Pulmonary Embolism, Pyrexia, Skin Reaction, Somnolence, Peripheral Sensory Neuropathy, Constipation, Herpes Zoster, Herpes Simplex, Transient Ischaemic Attack, Type 1 Diabetes Mellitus, Peripheral Motor Neuropathy, Thrombocytopenia, Pneumonia, Vomiting, Nausea, Ischaemic Stroke, Toxicity To Various Agents, Anxiety, Cardiac Failure, Diarrhoea, Hallucination, Visual, Intestinal Gangrene, Vertigo, Haemorrhagic Stroke, Treatment Failure, Neutropenia, Neuralgia, Deep Vein Thrombosis, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral

Thalidomide
    Dosage: escalated by 50 mg every 3 weeks
    Administration route: Oral



Possible Dexamethasone side effects in male

Reported by a consumer/non-health professional from United States on 2012-03-16

Patient: male, weighing 99.9 kg (219.7 pounds)

Reactions: Abdominal Pain, Tinnitus, Pain in Extremity, Hypertensive Heart Disease, Hyperglycaemia, Anaemia, Mental Status Changes, Pulmonary Embolism, Lactic Acidosis, Tinea Pedis, Cardio-Respiratory Arrest, Hepatomegaly, Dehydration, Pulmonary Oedema, Neutropenia, Deep Vein Thrombosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Sodium Chloride
    Dosage: 100 to 250 cc
    Start date: 2011-01-31
    End date: 2011-04-08

Cisplatin
    Dosage: 1-5 x3; 35mg
    Start date: 2011-01-31
    End date: 2011-04-08

Dexamethasone Sodium Phosphate
    Dosage: d 1-5 x3 cycle
    Indication: Nausea
    Start date: 2011-01-31
    End date: 2011-04-06

Dexamethasone
    Dosage: 4 tablet;
    Indication: Vomiting
    Start date: 2011-03-21
    End date: 2011-03-25

Etoposide
    Dosage: 230 milligram; 1-5 x4
    Indication: Seminoma
    Start date: 2011-01-31
    End date: 2011-04-08

Other drugs received by patient: Ondansetron; Aprepitant; Mannitol; Palonosetron Hydrochloride



Possible Dexamethasone side effects in male

Reported by a physician from United States on 2012-03-09

Patient: male, weighing 100.0 kg (220.0 pounds)

Reactions: Abdominal Pain, Tinnitus, Pain in Extremity, Anaemia, Hypertensive Heart Disease, Hyperglycaemia, Mental Status Changes, Pulmonary Embolism, Lactic Acidosis, Tinea Pedis, Hepatomegaly, Cardio-Respiratory Arrest, Dehydration, Pulmonary Oedema, Neutropenia, Deep Vein Thrombosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone Sodium Phosphate
    Indication: Prophylaxis of Nausea and Vomiting

Etoposide
    Dosage: 230 mg once daily d 1-5 x 4 cycles
    Indication: Seminoma
    Start date: 2011-01-31
    End date: 2011-04-08

Cisplatin
    Dosage: 45 mg d 1-5 x 3 cycles; 35 mg on cycle 4
    Indication: Seminoma
    Start date: 2011-01-31
    End date: 2011-04-08

Dexamethasone Sodium Phosphate
    Indication: Vomiting

Dexamethasone
    Dosage: 4 tablets (2 tablets twice daily)
    Administration route: Oral
    Indication: Vomiting
    Start date: 2011-03-21
    End date: 2011-03-25

Sodium Chloride
    Dosage: 100 to 250 ml
    Start date: 2011-01-31
    End date: 2011-04-08

Dexamethasone Sodium Phosphate
    Dosage: 10 mg d 1-5 x 3 cycles
    Indication: Nausea
    Start date: 2011-01-31
    End date: 2011-04-06

Other drugs received by patient: Aloxi; Mannitol; Emend; Zofran



Possible Dexamethasone side effects in male

Reported by a physician from United States on 2012-03-05

Patient: male, weighing 99.9 kg (219.7 pounds)

Reactions: Abdominal Pain, Tinnitus, Pain in Extremity, Hypertensive Heart Disease, Hyperglycaemia, Anaemia, Pulmonary Embolism, Mental Status Changes, Lactic Acidosis, Tinea Pedis, Hepatomegaly, Cardio-Respiratory Arrest, Dehydration, Pulmonary Oedema, Neutropenia, Deep Vein Thrombosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 1-5 x3; 35mg
    Start date: 2011-01-31
    End date: 2011-04-08

Sodium Chloride
    Dosage: 100 to 250 cc
    Start date: 2011-01-31
    End date: 2011-04-08

Dexamethasone
    Dosage: 4 tablet;
    Indication: Vomiting
    Start date: 2011-03-21
    End date: 2011-03-25

Dexamethasone Sodium Phosphate
    Dosage: d 1-5 x3 cycle
    Indication: Nausea
    Start date: 2011-01-31
    End date: 2011-04-06

Etoposide
    Dosage: 230 milligram; 1-5 x4
    Indication: Seminoma
    Start date: 2011-01-31
    End date: 2011-04-08

Other drugs received by patient: Mannitol; Aprepitant; Ondansetron; Palonosetron Hydrochloride



Possible Dexamethasone side effects in 72 year old male

Reported by a physician from United States on 2012-03-01

Patient: 72 year old male, weighing 83.0 kg (182.6 pounds)

Reactions: Electrocardiogram QT Prolonged, Abdominal Pain, Pulmonary Embolism, Mental Status Changes, Fatigue, Haematoma, Decreased Appetite, Anaemia, Hypotension, Blood Lactic Acid Increased, Staphylococcal Infection, Oliguria, Hypophagia, Dehydration, Septic Shock, Asthenia, Venous Occlusion, Deep Vein Thrombosis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Temozolomide
    Dosage: ; po
    Administration route: Oral
    Indication: Glioblastoma Multiforme
    Start date: 2010-02-22

Dexamethasone
    Dosage: 4 mg;
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-15

ABT-888
    Dosage: 20 mg;qd;po
    Administration route: Oral
    Indication: Glioblastoma Multiforme
    Start date: 2010-02-22

Other drugs received by patient: Multi-Vitamin; Zyflamend X; Ascorbic Acid; Colecaliciferol; Ascorbic Acid



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012